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Objectives: Circadian blood pressure (BP) pattern is diverse in patients with essential
hypertension. In this study, the relationship between circadian BP pattern and
coronary artery disease (CAD) in hypertensive patients was investigated.
Methods: A total of 716 hypertensive patients (390 men, 326 women) from 2012 to
2013 were included in the study. All other hypertensive patients were excluded if (1)
<18 or >90 years old; (2) pregnant women; (3) under antihypertensive treatment; (4)
BP measurements over 160/100 mmHg; (5) night-work employment; (6) suffering
acute stroke or myocardial infarction within the past 6 months; (7) with sleep apnea
syndrome; (8) evidence of disease or conditions responsible for secondary hyper-
tension; (9) could not tolerate the ambulatory blood pressure monitoring (ABPM);
(10) history of any arrhythmia, congestive heart failure, hepatic failure, kidney failure
and signiﬁcant systemic disease. Circadian BP patterns were evaluated with the 24
hours ABPM and divided into dipper (10-20% SBP fall), non-dipper (0-10% SBP
fall), extreme-dipper (>20% SBP fall) and reverse dipper (SBP nocturnal rise)
according to the nocturnal reduction of systolic blood pressure (SBP). We made the
diagnosis of CAD based on syndrome, electrocardiogram, blood tests (cardiac
markers) and cardiac stress testing or coronary angiogram. Descriptive results are
presented as percentages for discrete variables and as means (standard deviation) for
continuous variables. Multivariate logistic regression analyses were used to study the
relationship between the incidence of CAD and the circadian patterns of BP.
Results: In our study, the BP of 171 patients (23.8%) showed a reverse dipper pattern,
while 370 patients (51.5%) had a non-dipper pattern and 177 patients (24.7%) had a
dipper pattern. Patients with reverse dipper pattern were older (P<0.01), more often
smokers (P<0.01) and had a remarkably higher fasting glucose (P<0.01). Impor-
tantly, the percentage of CAD (P<0.01) and diabetes (P<0.05) were higher among the
patients with reverse dipper pattern. After multivariate logistic regression analysis,
reverse dipper pattern of BP was an independent factor for the incidence of CAD (OR
1.427; 95% CI 1.360-1.498; P<0.01). The result of our study also suggested that 24h-
SBP (OR 1.012; 95% CI 1.011-1.014; P<0.01) and 24h-DBP (OR 1.053; 95% CI
1.050-1.055; P<0.01) were closely related to CAD. Furthermore, age (OR 1.041; 95%
CI 1.027-1.056; P<0.01), diabetes (OR 1.630; 95% CI 1.123-2.366; P<0.05), tri-
glycerides (OR 1.258; 95% CI 1.056-1.499; P<0.05) were independently associated
with a reversed dipper BP pattern.
Conclusions: Reverse dipper pattern of BP examined with the 24h ABPM is an
independent predictor for CAD. The BP of hypertensive patients with CAD and
diabetes were more frequently found to be reverse dipper pattern.
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Objectives: To evaluate the expression of soluble vascular endothelial growth factor
receptor 2 (sVEGFR2) in plasma of hypertensive and hypertensive diabetic patients.
Methods: In this cross-sectional study, eighty-eight cases were enrolled, which were
divided into hypertensive group (n¼31), hypertensive diabetic group (n¼31) and
control group (n¼26). Blood pressure (BP) was obtained from each participant with
mercury sphygmomanometer. The expressions of sVEGFR2 and superoxide dis-
mutase (SOD) were measured by ELISA. Serum lipid proﬁle, glucose and glycosy-
lated hemoglobin A1C (GHbA1c) levels were detected.
Results: The levels of total cholesterol (TC) and body mass index (BMI) were
signiﬁcantly higher in the hypertensive group than those in control group (P<0.05).
The levels of TC, triglyceride (TG), low density lipoprotein cholesterol (LDL-C),
BMI, waist circumference were signiﬁcantly higher in the hypertensive diabetic group
than those in control group (P<0.05). The mean plasma levels of sVEGFR2 and SOD
in both hypertensive diabetic group and hypertensive group were signiﬁcantly
decreased compared to that in the normal group (P<0.05). While the mean plasma
levels of sVEGFR2 and SOD in hypertensive diabetic group were signiﬁcantly
decreased compared to the hypertensive group (P<0.05). There was a signiﬁcantly
positive correlation between sVEGFR2 and SOD in the whole study population
(r¼ 0.224, P¼ 0.0036).
Conclusions: Soluble VEGFR2 expression is decreased in both hypertensive and
hypertensive diabetic patients, and more decreased in hypertensive diabetic patients.
This study indicates that decreased SOD expression may contribute to the reduction of
sVEGFR2. Angiogenesis in these patients is impaired. So sVEGFR2 in plasma mayC176 JACC Vol 64/16/Suppl C j October 16–1be used as a biomarker to assess angiogenesis impairment in patients with hyper-
tension and diabetes.
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Objectives: (1) To investigate the ambulatory blood pressure (ABP) characteristics of
patients who have chronic kidney disease (CKD) complicated with hypertension.(2)
To compare the difference of blood pressure control rate between ABP and ofﬁce
blood pressure (OBP).
Methods: We selected 225 CKD patients complicated with hypertension and 107
essential hypertensives with normal renal function in our hospital during 2012.5-
2013.2. The general information and blood pressure information about these patients
were recorded. Statistically analyzing the ABP characteristics, ABP and OBP control
rate. Analyzing the “White-coat” effect and Pseudo-blood pressure control rate.
Results: (1) Compared with normal renal function hypertensives, the 24h SBP,
nocturnal BP, 24hBP load, diurnal BP load and nocturnal BP load in CKD patients are
signiﬁcantly higher (P<0.05), the anti-dipper BP rate (32.1% vs 5.6%, P<0.05) and
dipper BP rate (15.6% vs 34.6%, P<0.05) in CKD 5 patients are signiﬁcantly
different. There are negative correlation between 24h BP, diurnal BP, nocturnal BP,
BP load and eGFR (P<0.001). (2) Compared with normal renal function hyperten-
sives, the ABP control rate (13.7% vs 28.9%, P<0.05), nocturnal BP control rate
(13.7% vs 59.8%, P<0.05) and nocturnal SBP control rate (15.8% vs 66.8%, P<0.05)
are lower in CKD patients. (3) The ABP control rate is higher than OBP rate in
hypertensives with CKD1-2, and the ABP control rate is lower than OBP control rate
in hypertensives with CKD5 reversely.
Conclusions: (1) The nocturnal blood pressure control rate, which is signiﬁcantly
lower in CKD patients complicated with hypertension, should be attached more
attention. (2) CKD patients complicated with hypertension have a higher incidence of
Pseudo-blood pressure control rate. The OBP is not a good method to judge the blood
pressure control.
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Objectives: (1) To investigate the drug-drug interaction between tacrolimus
and amlodipine in post transplantation hypertension (PTH) patients. (2) To build a
population pharmacokinetics (PPK) model of tacrolimus in PTH patients.
Methods: (1) Prospective research on inﬂuence of amlodipine on tacrolimus phar-
macokinetics was developed in 23 PTH patients hospitalized during April 2012 and
January 2013. At 3 days after tacrolimus administration, and 7 days after amlodipine
administration, collect 2 ml anticoagulant peripheral vein blood at just predose and
0.5, 1, 2, 8, 12 h after dose. Detect the whole blood concentration of tacrolimus using
microparticle enzyme immunoassay analysis method. Patients with uncontrolled
hypertension before amlodipine administration can give antihypertensive agents
expect CCB to control blood pressure. Analysis the gene polymorphism by poly-
merase chain reactionrestriction polymorphism length fragment method, divide
patients into extensive metabolism (EM) and poor metabolism (PM) groups. Compare
the tacrolimus steady-state concentration/dose (C/D), area uder concentration-time
curve (AUC) and blood pressure of PTH patients before and after amlodipine
co-administration. (2) Collect 48 PTH patients using tacrolimus prospectively, sam-
pling method was same with the previous part. Collect demographics data, medication
data and blood concentration data of tacrolimus, etc. PPK analysis is conducted by
using NONMEM. Fit the data with one-compartment model and two-compartment
model respectively. Choose the best one as base model. Build full model with
stepwise regression method, then exclude the covariates which is not signiﬁcant, and
obtain the ﬁnal model. Conduct internal invalidation on ﬁnal model by using
Bootstrap method.
Results: (1) In 23 PTH patients, there were 13 male, 10 female. The mean age was
37.38.8 years. After combined with amlodipine for over 1 week, tacrolimus steady-
state C/D of PTH patients at 0 h, 2 h, 8 h, 12 h and AUC0-12h were elevated signif-
icantly (P<0.05). Systolic blood pressure and diastolic blood pressure were lowered
by 17.8 and 6.1 mmHg respectively. Tacrolimus AUC0-12h of CYP3A4 EM and PM
patients after amlodipine combined were increased by 1.2 and 1.1 times respectively
(P<0.05); Tacrolimus AUC0-12h of CYP3A5 EM and PM patients after amlodipine
combined were increased by 0.7 and 1.2 times respectively (P<0.05). (2) 48 PTH
patients (33 male, 15 female, mean age 35.08.9 years) with 552 samples were
included into the PPK analysis. A two-compartment model with ﬁrst-order absorption
and elimination was chosed as base model, model parameters included apparent
clearance, distribution volume of central compartment, distribution volume of pe-
ripheral compartment, clearance between compartments and absorption rate. CYP3A5
and hematocrit (HCT) was included into the ﬁnal model of clearance, amlodipine was9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
